Chronic obstructive pulmonary disease after myocardial infarction in the community

Francesca Bursi1, Robert Vassallo, Susan A Weston

  • 1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Abstract

Insights

The prevalence of chronic obstructive pulmonary disease (COPD) in myocardial infarction (MI) patients has doubled over time. COPD significantly increases mortality risk after MI, independent of other factors.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Myocardial infarction (MI) and chronic obstructive pulmonary disease (COPD) are prevalent conditions with shared risk factors.
  • Previous studies on COPD prevalence in MI patients yielded conflicting results regarding impact and trends.

Purpose of the Study:

  • To determine the prevalence of COPD in MI patients within a defined community.
  • To assess the impact of COPD on mortality following MI.
  • To analyze changes in these associations over time.

Main Methods:

  • A cohort of 3,438 MI patients from Olmsted County, Minnesota (1979-2007) was analyzed.
  • COPD diagnosis was confirmed through medical record review.
  • Mortality and risk factors were tracked over a 5-year period.

Main Results:

  • COPD prevalence in MI patients increased from 7% to 15% between 1979-1985 and 2000-2007.
  • Patients with COPD had significantly worse 5-year survival rates (46%) compared to those without COPD (68%).
  • The increased mortality risk associated with COPD was independent of age, risk factors, and did not change over time.

Conclusions:

  • COPD prevalence has risen among MI patients.
  • COPD is an independent predictor of increased mortality post-MI.
  • Optimizing care for MI patients with COPD is crucial due to their high-risk status.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...